Perrigo Company plc Deferred Tax Assets, Net of Valuation Allowance, Current
Perrigo Company plc (PRGO) had Deferred Tax Assets, Net of Valuation Allowance, Current of $0 as of 2016-12-31, per its 10-K filed 2017-05-22.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2017-05-22
- 2016-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $0.00.
- 2015-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $0.00.
- 2015-09-26: Deferred Tax Assets, Net of Valuation Allowance, Current $69.00M.
- 2015-06-27: Deferred Tax Assets, Net of Valuation Allowance, Current $148.20M; Deferred Tax Assets, Net of Valuation Allowance, Current as first filed $122.30M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current | Deferred Tax Assets, Net of Valuation Allowance, Current as first filed |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-05-22 | |
| 2015-12-31 | $0.00 10-K · filed 2017-05-22 | |
| 2015-09-26 | $69.00M 10-Q · filed 2015-11-02 | |
| 2015-06-27 | $148.20M 10-K · filed 2017-05-22 | $122.30M 10-K · filed 2015-08-13 |
| 2015-03-28 | $69.90M 10-Q · filed 2015-04-29 | |
| 2014-12-27 | $66.60M 10-Q · filed 2015-02-05 | |
| 2014-09-27 | $64.60M 8-K · filed 2014-11-20 | |
| 2014-06-28 | $62.80M 10-K · filed 2017-05-22 | |
| 2014-03-29 | $66.10M 10-Q · filed 2014-05-07 | |
| 2013-12-28 | $61.60M 10-Q · filed 2014-02-06 | |
| 2013-06-29 | $47.10M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |